Health Care & Life Sciences » Pharmaceuticals | Corium International Inc.

Corium International Inc. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
50,270.00
42,440.00
40,921.00
33,023.00
31,864.00
Cost of Goods Sold (COGS) incl. D&A
37,225.00
36,142.00
34,294.00
28,679.00
26,572.00
Gross Income
13,045.00
6,298.00
6,627.00
4,344.00
5,292.00
SG&A Expense
12,021.00
16,460.00
27,639.00
33,253.00
45,047.00
EBIT
1,024.00
10,162.00
21,012.00
28,909.00
39,755.00
Unusual Expense
7,381.00
7,093.00
-
-
-
Non Operating Income/Expense
177.00
112.00
12.00
15.00
6.00
Interest Expense
7,705.00
6,961.00
7,446.00
7,947.00
8,303.00
Pretax Income
13,876.00
9,911.00
28,447.00
36,700.00
47,786.00
Income Tax
1.00
1.00
3.00
3.00
7.00
Consolidated Net Income
13,877.00
9,912.00
28,450.00
36,703.00
47,793.00
Net Income
13,877.00
9,912.00
28,450.00
36,703.00
47,793.00
Net Income After Extraordinaries
13,877.00
9,912.00
28,450.00
36,703.00
47,793.00
Net Income Available to Common
13,877.00
9,912.00
28,450.00
36,703.00
47,793.00
EPS (Basic)
0.75
0.99
1.52
1.65
1.64
Basic Shares Outstanding
18,592.40
10,043.60
18,709.30
22,282.60
29,070.80
EPS (Diluted)
0.75
0.99
1.52
1.65
1.64
Diluted Shares Outstanding
18,592.40
10,043.60
18,709.30
22,282.60
29,070.80
EBITDA
3,457.00
7,385.00
18,375.00
26,395.00
37,963.00
Non-Operating Interest Income
9.00
7.00
23.00
171.00
278.00

About Corium International

View Profile
Address
235 Constitution Drive
Menlo Park California 94025
United States
Employees -
Website http://www.coriumgroup.com
Updated 09/14/2018
Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.